PAR : ALINS.PA

Intrasense S.A.

$0.224 EUR

$0.0 (-0.88%)

Volume
6.67K
Average Volume
56.16K
Market Capitalization
$11.8M
P/E Ratio
-1.10
Dividend Yield
0.00%
Price Target
Year High
$0.43
Year Low
$0.19
Day High
Day Low
Payout Ratio
$0.00
Current Ratio
$1.26
Company Overview

PAR

Alexandre Salvador

Medical - Healthcare Information Services

Healthcare

ALINS.PA

76

FR

EUR

33 4 67 13 01 30

F5333Q103

N/A

Liquidity Metrics

-0.08

1.26

1.26

0.41

0.00

Sales & Valuation

$2.96M

3.98

-1.83

-3.21

-0.07

Profitability

-$0.2

-$10.81M

-364.76%

-381.64%

283.66%

-135.22%

P/E Metrics

-1.10

0.02

0.02

Analyst Price Target & Rating

Sell

2/5

0 Analysts

%

Financial Health Scores

-7.53

2/9

$509.98K

$7.99M

$14.45M

-$16.57M

Key Metrics (TTM)

No key metrics data available.

Company Executives
Name Title
Fanny Louvet-de Verchere Chief Product & Marketing Officer
Marion Peureux Human Resources Manager
Jerome Thiebaud Chief Business Officer
Stephen Armand Chief Executive Officer
Pierre Voiriot Chief Technical Officer
Poll Results

No votes yet today — be the first to share your view!

About Intrasense S.A. (PAR:ALINS.PA) Stock

Established in 2004 and headquartered in Montpellier, France, Intrasense S.A. specializes in the global development of sophisticated software for visualizing and analyzing diverse medical imaging data, marketed under its Myrian brand. The company's offerings feature the Myrian Imaging Layer, a versatile multi-modality visualization platform tailored for professionals in the health industry. It also provides Myrian Studio, a dedicated development environment empowering innovators, industrial partners, spin-offs, and research institutions to build medical imaging applications. Furthermore, Intrasense leverages its Myrian technologies to facilitate the creation of biomarkers and artificial intelligence solutions. A key component of its product line is Myrian Clinical Apps, an extensive collec ... tion of advanced post-processing clinical applications. This portfolio encompasses specialized modules like Myrian XP-Breast, XP-Prostate, XP-Liver, XP-Mammo, XP-Lung, XP-Colon, XP-Vessel, and XP-Cardiac, alongside Myrian XL-Onco for tracking lesions. These applications, which also provide solutions for analyzing specific pathologies or organs, offer various tools for interpreting data from MRI, CT scans, conventional radiology, and nuclear imaging examinations.

Frequently Asked Questions

What is the current Intrasense S.A. (ALINS.PA) stock price?

Intrasense S.A.(PAR:ALINS.PA) stock price is $0.224 in the last trading session. During the trading session, ALINS.PA stock reached the peak price of $0.43 while $0.19 was the lowest point it dropped to. The percentage change in ALINS.PA stock occurred in the recent session was --0.88% while the dollar amount for the price change in ALINS.PA stock was -$0.0.

ALINS.PA's industry and sector of operation?

The PAR listed ALINS.PA is part of Medical - Healthcare Information Services industry that operates in the broader Healthcare sector.

Who are the executives of ALINS.PA?

Fanny Louvet-de Verchere | Chief Product & Marketing Officer
Marion Peureux | Human Resources Manager
Jerome Thiebaud | Chief Business Officer
Stephen Armand | Chief Executive Officer
Pierre Voiriot | Chief Technical Officer

How many employees does ALINS.PA have?

Number of ALINS.PA employees currently stands at 76. ALINS.PA operates from 1231, avenue du Mondial 98, Montpellier, OCC 34000, FR.

Link for ALINS.PA official website?

Official Website of ALINS.PA is: https://www.intrasense.fr

How do I contact ALINS.PA?

ALINS.PA could be contacted at phone #33 4 67 13 01 30 and can also be accessed through its website. ALINS.PA operates from 1231, avenue du Mondial 98, Montpellier, OCC 34000, FR.

How many shares of ALINS.PA are traded daily?

The average number of ALINS.PA shares traded daily for last 3 months was 56.16K.

What is the market cap of ALINS.PA currently?

The market value of ALINS.PA currently stands at $11.8M with its latest stock price at $0.224